ArticleBMC geriatrics2026
Longitudinal association between sarcopenia and comorbidity of mild cognitive impairment and depression among older adults in China: the moderating effect of non-obesity.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia, mild cognitive impairment (MCI), and depression could cause great distress in the lives of older adults and frequently co-occur, yet their interrelationships remain elusive. This study seeks to assess the link between sarcopenia and the comorbid MCI and depression in older Chinese, and their longitudinal impact.
methodsWe used data from the 2015 (wave 3) and 2018 (wave 4) surveys of the China Health and Retirement Longitudinal Study (CHARLS). Cross-sectional analysis of the 2015 data estimated the baseline prevalence of sarcopenia and its comorbidity with mild cognitive impairment (MCI) and depression. Longitudinal analysis of the 2015-2018 data employed multivariate logistic regression models, adjusted for demographic and health covariates, to examine the prospective association between sarcopenia and incident comorbidities; stratified analyses were additionally conducted among obese individuals. To illustrate the impact of sarcopenia on comorbidity onset, Cox proportional-hazards models were fitted to the 2011-2018 (waves 1-4) longitudinal data to estimate the association between sarcopenia and incident comorbidities.
resultsDuring the follow-up period from 2015 to 2018, among 2773 individuals, 190 developed comorbidities of mild cognitive impairment and depression. After adjusting for covariates, compared to non-sarcopenic individuals, those with possible sarcopenia (OR = 2.952, 95% CI: 2.104-4.141, P < 0.01) and sarcopenia (OR = 3.105, 95% CI: 2.064-4.670, P < 0.01) were associated with a higher incidence of comorbidity (p < 0.001). Furthermore, we observed that the incidence of comorbidity was 15.38% points lower in non-obese individuals with sarcopenia compared to those who were obese and had sarcopenia. Compared to the normal group, individuals with obesity who had possible sarcopenia exhibited a higher risk of developing comorbidities(OR = 2.411, 95% CI: 1.472-3.946, P < 0.001), and the sarcopenia group had an even higher risk (OR = 7.580, 95% CI: 2.578-22.289, P < 0.001) in the fully adjusted model accounting for age, gender, residential area, education level, marital status, former/current smoking, former/current alcohol use, other comorbidities. However, in the non-obese subgroup, neither possible sarcopenia group (OR = 1.875, 95% CI: 0.858-4.097, P > 0.05) nor sarcopenia group (OR = 1.222, 95% CI: 0.590-2.529, P > 0.05) showed a statistically significant association with the development of comorbidity.
conclusionThese findings suggest that sarcopenia increases the risk of comorbid MCI and depression in older adults; however, this association was only observed in obese individuals, with non-obesity status significantly attenuating the risk. These findings suggest that sarcopenia may represent a potential target for preventive strategies, particularly among obese older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.